<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="364729">
  <stage>Registered</stage>
  <submitdate>4/08/2013</submitdate>
  <approvaldate>6/08/2013</approvaldate>
  <actrnumber>ACTRN12613000873729</actrnumber>
  <trial_identification>
    <studytitle>Effect of regional anaesthesia with supraclavicular brachial plexus block on the vessels of the upper arm operated for vascular access</studytitle>
    <scientifictitle>Effect of supraclavicular brachial plexus block on the regional hemodynamics of the upper arm in patients operated for vascular access</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>regional hemodynamics of the upper limb after supraclavicular brachial plexus block</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Other anaesthesiology</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>1. No pre-medication

2. Standard monitoring: ECG, non invasive blood pressure, oxymetry.

3. Peripheral venous cannulation

4. Ultrasound guided supraclavicular block using 15 ml lidocaine 2% + 15 ml bupivacaine 0.5% 

The duration of each procedure is approximately 15 minutes</interventions>
    <comparator>Not applicable</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: Devices</interventioncode>
    <interventioncode>Treatment: Surgery</interventioncode>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>brachial artery blood flow measured with ultrasound-doppler at mid arm
</outcome>
      <timepoint>T0: before performing the block
T15: 15 minutes after the procedure is completed
T30: 30 minutes after the procedure is completed</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>cephalic vein diameter measured with ultrasound at mid arm
</outcome>
      <timepoint>T0: before performing the block
T15: 15 minutes after the procedure is completed
T30: 30 minutes after the procedure is completed</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>brachial artery pulsatility and resistivity indexes measured with ultrasound-doppler at mid arm
</outcome>
      <timepoint>T0: before performing the block
T15: 15 minutes after the procedure is completed
T30: 30 minutes after the procedure is completed</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Success rate for surgical anaesthesia : seccess is defined by the absence of pain at skin incision
</outcome>
      <timepoint>40 minutes, after the procedure is completed
</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients requiring hemodialysis and scheuled to elective confection of humeral-cephalic arteriovenous fistula under regional anaesthesia
</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1. Patient refusal
2. Allergy to local anesthetics
3. Existing neurological disorders, neuropathy of the operative extremity
4. Infection at site of needle puncture
5. Coagulation disorders</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment>Subjects for the study will be recruited from the operating list
</concealment>
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/07/2013</anticipatedstartdate>
    <actualstartdate>1/07/2013</actualstartdate>
    <anticipatedenddate />
    <actualenddate>15/08/2013</actualenddate>
    <samplesize>15</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Tunisia</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Military Hospital of Tunis</primarysponsorname>
    <primarysponsoraddress>Montfleury 1089 Tunis
</primarysponsoraddress>
    <primarysponsorcountry>Tunisia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Military Hospital of Tunis
</fundingname>
      <fundingaddress>Montfleury 1089 Tunis
</fundingaddress>
      <fundingcountry>Tunisia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Perpheral nerve blocks are known to induce many changes in the local circulation such as vasodilation. We use the ultrasound-doppler to show and quantify the variations of the regional hemodynamics of the upper arm after a supraclavicular brachial plexus block.
</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Military Hospital of Tunis Local Ethics Committee</ethicname>
      <ethicaddress>Military Hospital of Tunis 
Monfleury
1089
Tunis</ethicaddress>
      <ethicapprovaldate>4/06/2013</ethicapprovaldate>
      <hrec>061/013</hrec>
      <ethicsubmitdate />
      <ethiccountry>Tunisia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Radhouane Bousselmi</name>
      <address>Military Hospital of Tunis 15 Avenue de la Republique 2000 Bardo
</address>
      <phone>+216 22 622 495</phone>
      <fax />
      <email>rdh.bousselmi@gmail.com</email>
      <country>Tunisia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Radhouane Bousselmi</name>
      <address>Military Hospital of Tunis 15 Avenue de la Republique 2000 Bardo
</address>
      <phone>+216 22 622 495</phone>
      <fax />
      <email>rdh.bousselmi@gmail.com</email>
      <country>Tunisia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Radhouane Bousselmi</name>
      <address>Military Hospital of Tunis 15 Avenue de la Republique 2000 Bardo
</address>
      <phone>+216 22 622 495</phone>
      <fax />
      <email>rdh.bousselmi@gmail.com</email>
      <country>Tunisia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>